-
Prostate-Specific Membrane Antigen-Targeted Therapies for Prostate Cancer: Towards Improving Therapeutic Outcomes - Beyond the Abstract
17 Apr 2024 22:42 GMT
… Receptor Radionuclide Therapy by the PARP Inhibitor Olaparib. Theranostics. 2016;6 …
-
Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated Melanoma
17 Apr 2024 21:19 GMT
… regulate DNA repair, and PARP inhibitors possess the potential to … Preclinical data suggest that PARP inhibition can result in STING … has been observed with PARP inhibitors combined with immune … regard to the efficacy of PARP inhibitors in melanoma, according …
-
Ultimovacs downsizes to funnel funds to cancer vaccine programme
17 Apr 2024 17:42 GMT
… ), a poly-ADP ribose polymerase (PARP) inhibitor, as a second line …
-
Toronto researchers uncover human DNA repair by nuclear metamorphosis
17 Apr 2024 11:27 GMT
… a class of drugs called PARP inhibitors. PARP is an enzyme that … and helps repair damaged DNA. PARP inhibitors block the enzyme from … cells are more resistant to PARP inhibitors,” says Hakem.
Partnerships among …
-
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
17 Apr 2024 13:10 GMT
… development of stenoparib, a novel PARP/Tankyrase inhibitor for advanced …
-
TOPAZ─1 phase III trial shows AstraZeneca's Imfinzi plus chemotherapy doubled OS rate at three years for patients with advanced biliary tract cancer
17 Apr 2024 03:44 GMT
… (olaparib), a first-in-class PARP inhibitor, is approved in the …
-
A Risky Bet: Zai Lab's Uncertain Future
17 Apr 2024 00:58 GMT
… key asset is Zejula, a PARP inhibitor in-licensed from GSK … , Zejula became the second approved PARP inhibitor in China. Zai Lab … , Hengrui and Beigene's PARP inhibitors were also approved. The …
-
Treating Prostate Cancer at Any Stage
16 Apr 2024 16:37 GMT
… called poly(ADP-ribose) polymerase (PARP) inhibitors—have recently received FDA …
-
IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
16 Apr 2024 11:18 GMT
… .
Olaparib, a first-in-class PARP inhibitor, is approved in the …
-
Indian oncology landscape has room for improvement in cancer detection rates: Dr Neil Iyengar
16 Apr 2024 10:24 GMT
… , along with novel agents like PARP inhibitors, hold promise in enhancing …